Betulinic acid as new activator of NF-κB : molecular mechanisms and implications for cancer therapy

Hubert Kasperczyk; Katia LA FERLA-BRÜHL; Mike Andrew Westhoff; Lars Behrend; Ralf Michael Zwacka; Klaus-Michael Debatin; Simone Fulda; Essam Hassan Ibrahim

doi:10.1038/sj.onc.1208842

Back

Betulinic acid as new activator of NF-κB : molecular mechanisms and implications for cancer therapy

Journal article

Peer reviewed

Betulinic acid as new activator of NF-κB : molecular mechanisms and implications for cancer therapy

Hubert Kasperczyk, Katia LA FERLA-BRÜHL, Mike Andrew Westhoff, Lars Behrend, Ralf Michael Zwacka, Klaus-Michael Debatin, Simone Fulda and Essam Hassan Ibrahim

Oncogene, Vol.24(46), pp.6945-6956

20/10/2005

DOI: https://doi.org/10.1038/sj.onc.1208842

PMID: 16007147

Abstract

Biological and medical sciences

Cell physiology

Cell transformation and carcinogenesis. Action of oncogenes and antioncogenes

Fundamental and applied biological sciences. Psychology

Molecular and cellular biology

Metrics

1 Record Views

See more details

Details

Title: Betulinic acid as new activator of NF-κB : molecular mechanisms and implications for cancer therapy
Creators - without role: Hubert Kasperczyk - University Hospital Ulm
Katia LA FERLA-BRÜHL - University Hospital Ulm
Mike Andrew Westhoff - University Hospital Ulm
Lars Behrend - University of Ulm
Ralf Michael Zwacka - University of Ulm
Klaus-Michael Debatin - University Hospital Ulm
Simone Fulda - University Hospital Ulm
Essam Hassan Ibrahim - King Khalid University
Publication Details: Oncogene, Vol.24(46), pp.6945-6956
Publisher: Nature Publishing
Identifiers: 9922115008331
Academic Unit: King Khalid University
Language: English
Resource Type: Journal article